Antibody levels against hepatitis B virus after hepatitis B vaccination in Egyptian diabetic children and adolescents

References

• WHO. Hepatitis B vaccine. W.W.E. Record ed 2009; 84: 405-420.
   Google Scholar
• Lehman EM, Wilson ML. Epidemiology of hepatitis viruses among hepatocellular carcinoma cases and healthy people in Egypt: a systematic review and meta-analysis. Int J Cancer 2009; 124:690 - 7; http://dx.doi.org/10.1002/ijc.23937; PMID: 18973270
   PubMed Web of Science ®Google Scholar
• Youssef A, Yano Y, Utsumi T, abd El-alah EM, abd El-Hameed Ael-E, Serwah Ael-H, et al. Molecular epidemiological study of hepatitis viruses in Ismailia, Egypt. Intervirology 2009; 52:123 - 31; http://dx.doi.org/10.1159/000219385; PMID: 19468235
   PubMed Web of Science ®Google Scholar
• Schillie S, Smith E., Reilly M, Murphy T. Odds of acute hepatitis B among persons with diabetes at eight emerging infections program sites. Advisory Committee on Immunization Practices October 2011.
   Google Scholar
• Madaliński K, Brzosko WJ, Malczewski B, Czyzyk A. Au-H.A.A. in sera of diabetic patients. Lancet 1971; 1:701 - 2; http://dx.doi.org/10.1016/S0140-6736(71)92708-5; PMID: 4102232
   PubMed Web of Science ®Google Scholar
• Whittle HC, Inskip H, Hall AJ, Mendy M, Downes R, Hoare S. Vaccination against hepatitis B and protection against chronic viral carriage in The Gambia. Lancet 1991; 337:747 - 50; http://dx.doi.org/10.1016/0140-6736(91)91367-4; PMID: 1672389
   PubMed Web of Science ®Google Scholar
• Da Villa G, Picciottoc L, Elia S, Peluso F, Montanaro F, Maisto T. Hepatitis B vaccination: universal vaccination of newborn babies and children at 12 years of age versus high risk groups. A comparison in the field. Vaccine 1995; 13:1240 - 3; http://dx.doi.org/10.1016/0264-410X(95)00056-7; PMID: 8578810
   PubMed Web of Science ®Google Scholar
• Chen HL, Chang MH, Ni YH, Hsu HY, Lee PI, Lee CY, et al. Seroepidemiology of hepatitis B virus infection in children: Ten years of mass vaccination in Taiwan. JAMA 1996; 276:906 - 8; http://dx.doi.org/10.1001/jama.1996.03540110060032; PMID: 8782640
   PubMed Web of Science ®Google Scholar
• Lin HH, Lin SS, Chiang YM, Wang LY, Huang LC, Huang SC, et al. Trend of hepatitis B virus infection in freshmen classes at two high schools in Hualien, Taiwan from 1991 to 1999. J Med Virol 2002; 67:472 - 6; http://dx.doi.org/10.1002/jmv.10125; PMID: 12115991
   PubMed Web of Science ®Google Scholar
• Specialist Panel on Chronic Hepatitis B in the Middle East. A review of chronic hepatitis B epidemiology and management issues in selected countries in the Middle East. J Viral Hepat 2012; 19:9 - 22; http://dx.doi.org/10.1111/j.1365-2893.2011.01511.x; PMID: 22187943
   PubMed Web of Science ®Google Scholar
• Zakaria S, Al-Boraey Y. A community-based study of viral hepatitis infection in Giza Governorate. Egypt: Seroprevalence, risk factors and associated morbidity. Med J Cairo Univ 2005; 73:899 - 912
   Google Scholar
• Pozzilli P, Arduini P, Visalli N, Sutherland J, Pezzella M, Galli C, et al. Reduced protection against hepatitis B virus following vaccination in patients with type 1 (insulin-dependent) diabetes. Diabetologia 1987; 30:817 - 9; http://dx.doi.org/10.1007/BF00275749; PMID: 2962892
   PubMed Web of Science ®Google Scholar
• Craven DE, Awdeh ZL, Kunches LM, Yunis EJ, Dienstag JL, Werner BG, et al. Nonresponsiveness to hepatitis B vaccine in health care workers. Results of revaccination and genetic typings. Ann Intern Med 1986; 105:356 - 60; http://dx.doi.org/10.7326/0003-4819-105-3-356; PMID: 2943202
   PubMed Web of Science ®Google Scholar
• Alper CA, Kruskall MS, Marcus-Bagley D, Craven DE, Katz AJ, Brink SJ, et al. Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med 1989; 321:708 - 12; http://dx.doi.org/10.1056/NEJM198909143211103; PMID: 2528067
   PubMed Web of Science ®Google Scholar
• Fabrizi F, Dixit V, Martin P, Messa P. Meta-analysis: the impact of diabetes mellitus on the immunological response to hepatitis B virus vaccine in dialysis patients. Aliment Pharmacol Ther 2011; 33:815 - 21; http://dx.doi.org/10.1111/j.1365-2036.2011.04589.x; PMID: 21281319
   PubMed Web of Science ®Google Scholar
• Leonardi S, Vitaliti G, Garozzo MT, Miraglia del Giudice M, Marseglia G, La Rosa M. Hepatitis B vaccination failure in children with diabetes mellitus? The debate continues. Hum Vaccin Immunother 2012; 8:448 - 52; PMID: 22370513
   PubMed Web of Science ®Google Scholar
• Martinetti M, De Silvestri A, Belloni C, Pasi A, Tinelli C, Pistorio A, et al. Humoral response to recombinant hepatitis B virus vaccine at birth: role of HLA and beyond. Clin Immunol 2000; 97:234 - 40; http://dx.doi.org/10.1006/clim.2000.4933; PMID: 11112362
   PubMed Web of Science ®Google Scholar
• Douvin C, Simon D, Charles MA, Deforges L, Bierling P, Lehner V, et al. Hepatitis B vaccination in diabetic patients. Randomized trial comparing recombinant vaccines containing and not containing pre-S2 antigen. Diabetes Care 1997; 20:148 - 51; http://dx.doi.org/10.2337/diacare.20.2.148; PMID: 9118762
   PubMed Web of Science ®Google Scholar
• Schillie SF, Spradling PR, Murphy TV. Immune response of hepatitis B vaccine among persons with diabetes: a systematic review of the literature. Diabetes Care 2012; 35:2690 - 7; http://dx.doi.org/10.2337/dc12-0312; PMID: 23173138
   PubMed Web of Science ®Google Scholar
• Marseglia GL, Scaramuzza A, d’Annunzio G, Comolli G, Gatti M, Lorini R. Successful immune response to a recombinant hepatitis B vaccine in young patients with insulin-dependent diabetes mellitus. Diabet Med 1996; 13:630 - 3; http://dx.doi.org/10.1002/(SICI)1096-9136(199607)13:7<630::AID-DIA137>3.0.CO;2-7; PMID: 8840096
   PubMed Web of Science ®Google Scholar
• Marseglia GL, Alibrandi A, d’Annunzio G, Gulminetti R, Avanzini MA, Marconi M, et al. Long term persistence of anti-HBs protective levels in young patients with type 1 diabetes after recombinant hepatitis B vaccine. Vaccine 2000; 19:680 - 3; http://dx.doi.org/10.1016/S0264-410X(00)00268-1; PMID: 11115688
   PubMed Web of Science ®Google Scholar
• Halota W, Muszyńska M, Pawłowska M. Hepatitis B virus serologic markers and anti-hepatitis B vaccination in patients with diabetes. Med Sci Monit 2002; 8:CR516 - 9; PMID: 12118201
   PubMedGoogle Scholar
• Wu JS, Hwang LY, Goodman KJ, Beasley RP. Hepatitis B vaccination in high-risk infants: 10-year follow-up. J Infect Dis 1999; 179:1319 - 25; http://dx.doi.org/10.1086/314768; PMID: 10228050
   PubMed Web of Science ®Google Scholar
• Huang LM, Chiang BL, Lee CY, Lee PI, Chi WK, Chang MH. Long-term response to hepatitis B vaccination and response to booster in children born to mothers with hepatitis B e antigen. Hepatology 1999; 29:954 - 9; http://dx.doi.org/10.1002/hep.510290349; PMID: 10051503
   PubMed Web of Science ®Google Scholar
• Lu CY, Chiang BL, Chi WK, Chang MH, Ni YH, Hsu HM, et al. Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination. Hepatology 2004; 40:1415 - 20; http://dx.doi.org/10.1002/hep.20490; PMID: 15565627
   PubMed Web of Science ®Google Scholar
• Zanetti AR, Mariano A, Romanò L, D’Amelio R, Chironna M, Coppola RC, et al, Study Group. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet 2005; 366:1379 - 84; http://dx.doi.org/10.1016/S0140-6736(05)67568-X; PMID: 16226616
   PubMed Web of Science ®Google Scholar
• McMahon BJ, Bruden DL, Petersen KM, Bulkow LR, Parkinson AJ, Nainan O, et al. Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up. Ann Intern Med 2005; 142:333 - 41; http://dx.doi.org/10.7326/0003-4819-142-5-200503010-00008; PMID: 15738452
   PubMed Web of Science ®Google Scholar
• Reda AA, Arafa MA, Youssry AA, Wandan EH, Ab de Ati M, Daebees H. Epidemiologic evaluation of the immunity against hepatitis B in Alexandria, Egypt. Eur J Epidemiol 2003; 18:1007 - 11; http://dx.doi.org/10.1023/A:1025805817101; PMID: 14598932
   PubMed Web of Science ®Google Scholar
• Shaaban FA, Hassanin AI, Samy SM, Salama SI, Said ZN. Long-term immunity to hepatitis B among a sample of fully vaccinated children in Cairo, Egypt. East Mediterr Health J 2007; 13:750 - 7; PMID: 17955755
   PubMedGoogle Scholar
• Shatat H, Kotkat A, Farghaly A, Omar S, Zayton S. A study of hepatitis B vaccine efficacy 10 years after compulsory vaccination in Egypt. J Egypt Public Health Assoc 2005; 80:495 - 508; PMID: 17187739
   PubMedGoogle Scholar
• Abushady EAE. G.M., Klena JD, Ahmed SF, Abdel-Wahab KSE, Fahmy SM. HBV vaccine efficacy and detection and genotyping of vaccineé asymptomatic breakthrough HBV infection in Egypt. World J Hepatol 2011; 147-156.
   Google Scholar
• Leonardi S, Del Giudice MM, Spicuzza L, Spina M, La Rosa M. Hepatitis B vaccine administered by intradermal route in patients with celiac disease unresponsive to the intramuscular vaccination schedule: a pilot study. Am J Gastroenterol 2010; 105:2117 - 9; http://dx.doi.org/10.1038/ajg.2010.195; PMID: 20818367
   PubMed Web of Science ®Google Scholar
• Hadler SC, Margolis HS. Hepatitis B immunization: vaccine types, efficacy, and indications for immunization. Curr Clin Top Infect Dis 1992; 12:282 - 308; PMID: 1386520
   PubMedGoogle Scholar
• Mast EE, Weinbaum CM, Fiore AE, Alter MJ, Bell BP, Finelli L, et al, Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep 2006; 55:RR-16 1 - 33, quiz CE1-4; PMID: 17159833
   PubMedGoogle Scholar